Sportsbook technology supplier Altenar has filed antitrust complaints against Sportradar with the European Commission and the UK Competition and Markets Authority (CMA), challenging the rival provider’s exclusive access to official data from major sports leagues.
The complaints, filed on 14 October, target agreements covering Major League Baseball (MLB), the National Basketball Association (NBA), the National Hockey League (NHL) and the Association of Tennis Professionals (ATP). Altenar argues that Sportradar’s control over official data and the live betting odds derived from it could restrict competition between sportsbook suppliers.
Neither regulator has confirmed opening a formal investigation, leaving the dispute at an early stage.
Altenar Seeks Access to Official Data and Betting Odds
Altenar, an Isle of Man-based sportsbook platform provider, is asking competition authorities to examine how Sportradar’s exclusive data agreements affect rival businesses.
The company has also requested interim measures from the CMA to restore access to essential data and odds while the matter is considered.
An Altenar spokesperson told Reuters that the company believes Sportradar is using its control of essential sports data to shut out competing businesses, arguing that bookmakers in the UK and EU should have a choice of suppliers.
The European Commission confirmed it had received information and was assessing it. The CMA said it does not comment on specific matters outside a formal investigation.
That distinction is important: neither authority has announced a finding against Sportradar, and the complaints themselves do not establish that competition law has been breached.
Dispute Follows Altenar’s US Antitrust Lawsuit
The European and UK complaints follow a separate lawsuit Altenar filed against Sportradar in a US federal court in New Jersey on 31 March 2026.
In that case, Altenar alleges that Sportradar supplied its official sports data for use outside the US from 2015, with annual payments eventually exceeding $6m. Altenar claims that a 2021 agreement excluded US rights while leaving the company expecting access under a separate arrangement, which it says was not delivered after Sportradar launched its ORAKO turnkey sportsbook platform in 2022.
Altenar further alleges that the renewal terms offered by Sportradar would have made its business unviable. It is seeking access to data on reasonable terms and damages under US antitrust law.
These remain allegations. Sportradar has described the US claims as without merit and has sought to move the dispute to arbitration in Switzerland under the parties’ agreement. The case had not received a ruling on that request in the latest account provided by iGaming Times.
Sportradar Rejects the Complaints
Sportradar has characterised the latest filings as duplicative and an attempt to apply pressure in existing commercial disputes. The company says it complies with antitrust laws in the markets where it operates.
The dispute raises a wider question for the sports betting industry: whether a company that controls exclusive official sports data and also sells competing sportsbook technology can restrict access in ways that disadvantage rival platforms.
Exclusive data rights are not automatically unlawful. The key issue will be whether the specific arrangements and conduct meet the relevant legal tests for restricting competition.
CMA Interim Measures Could Be the Next Turning Point
Altenar’s request for interim measures could prove to be the most immediate test of its UK complaint. The CMA can issue such directions only after opening a formal investigation, while the European Commission has its own requirements for interim action, including a risk of serious and irreparable harm to competition.
If either authority opens a case, the dispute could move beyond a commercial disagreement and into a formal examination of how official sports data is licensed and supplied to competing betting platforms.
For now, the outcome remains uncertain. The complaints have put Sportradar’s exclusive league agreements under renewed scrutiny, but the next significant development will depend on whether regulators decide to investigate.